Ik-B phosphorylation inhibitors (Cephalon)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameIk-B phosphorylation inhibitors (Cephalon)
Drug Alias NameIkappa-Beta phosphorylation inhibitors (Cephalon)indenopyrrolocarbazole kinase inhibitor (Cephalon)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInhibitor of nuclear factor kappa-B kinase subunit beta modulatorsNuclear factor NF-kappa-B complex inhibitors
TargetsInhibitor of nuclear factor kappa-B kinase subunit betaNuclear factor NF-kappa-B complex
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCephalon Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCephalon Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A